In April 2015, two high-profile chemistry bloggers — and their commenters — raised questions about a paper that had been published in PLOS ONE some 18 months earlier. More than three years later, the journal has now retracted the paper, with a notice that echoes the 2015 blog posts.
A group of editors of journals focused on the history of economics has gone public to urge Clarivate Analytics, which publishes a highly influential ranking of journals, to reconsider its decision to drop the titles from this year’s index.
Researchers have retracted a 2015 Nature paper about the molecular underpinnings of immune function after discovering they could not replicate key parts of the results.
What happened appears to be a case of “he said, she said:” Littman asked to retract the paper after his lab couldn’t reproduce it, and Huang insists the data remain correct, saying the process had been “unfair and done without due process:”
The Lancet chapter of the Paolo Macchiarini saga appears to finally be over.
In an editorial titled “The final verdict on Paolo Macchiarini: guilty of misconduct,” the editors of the journal announce that they are retracting two papers by the now-disgraced surgeon and colleagues “after receiving requests to do so from the new President of the Karolinska Institute (KI), Ole Petter Ottersen.” Late last month, Ottersen declared Macchiarini and six other researchers — including one of the whistleblowers in the case — guilty of misconduct.
Barislav Momčilović thinks that iodine status is — after iron deficiency — the “main public health” issue in the world today. So when he figured out what he believed was the best way to test levels of the mineral, he was determined to get the message out.
A little too determined, perhaps: He published the same information three times. And one journal caught on. Last week, Thyroid retracted “Hair Iodine for Human Iodine Status Assessment,” a 2014 paper that they say overlapped with two earlier works.
When the journal issued expressions of concern for four papers co-authored by José Ignacio Rodriguez-Crespo about the allegations (which had also been raised on PubPeer), it notified his institution, the Universidad Complutense de Madrid (UCM). The newly issued correction notices explain that UCM investigated the four papers, and the data support the results and conclusions. In two cases, the authors supplied the original data, and in the others, they replicated the experiments.
Rodriguez-Crespo declined to comment, saying only that the journal
Here’s a story that shows the lengths a public university — The University of Illinois at Chicago — went to block the release of information about a child psychiatry trial gone wrong, and how a reporter — Jodi S. Cohen of ProPublica — fought them effectively at every turn to reveal the truth.
Is open peer review the future? The EMBO Journal has offered it since 2009. eLife offers it. They’re not alone, although they’re still in the minority (a fact Irene Hames wishes would change). Elsevier, one of the world’s largest publishers, has tried a pilot of it, too, so we thought it would be worth finding out what happened. We spoke to Bahar Mehmani, Elsevier’s lead for reviewer experience, about the project, and lessons learned.
Reading reports of institutional investigations into allegations of misconduct can sometimes feel like reading a spy novel about science. And we’ve read a lot of them.
In a recent post that drew from one such report, we wrote:
Whenever we learn about misconduct cases at public universities, we file such public records requests to obtain more information because we believe, as did Justice Louis Brandeis, that sunlight is the best disinfectant.
But just as retraction notices are often unhelpful and even misleading, suggesting a lack of transparency, reports of institutional investigations can leave a lot to be desired, and reveal flaws in the the process that lead to them. As we and C.K. Gunsalus noted recently in JAMA: